Market Closed -
Other stock markets
|
|
5-day change | 1st Jan Change | |
59.6 EUR | -1.81% | +1.19% | -20.21% |
Nov. 24 | CAC40: up slightly, stalls at the 7300 pts mark | CF |
Nov. 24 | Equasens: share price up, broker confirms its recommendation | CF |
Sales 2023 * | 224M 241M | Sales 2024 * | 244M 263M | Capitalization | 896M 966M |
---|---|---|---|---|---|
Net income 2023 * | 47M 50.7M | Net income 2024 * | 55M 59.33M | EV / Sales 2023 * | 3,92x |
Net cash position 2023 * | 20.23M 21.82M | Net cash position 2024 * | 79.62M 85.89M | EV / Sales 2024 * | 3,35x |
P/E ratio 2023 * | 18,7x | P/E ratio 2024 * | 16,2x | Employees | - |
Yield 2023 * | 2,04% | Yield 2024 * | 2,14% | Free-Float | 32.23% |
More Fundamentals
* Assessed data
More news
1 day | -1.81% | ||
1 week | +1.19% | ||
Current month | +1.19% | ||
1 month | -13.62% | ||
3 months | -18.13% | ||
6 months | -25.13% | ||
Current year | -20.21% |
1 week
58.40
61.30

1 month
55.00
69.10

Current year
55.00
85.80

1 year
55.00
85.80

3 years
55.00
124.20

5 years
41.25
124.20

10 years
17.43
124.20

Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 1990 | |
Thierry Chapusot
FOU | Founder | 64 | 1996 |
Damien Maringer
CTO | Chief Tech/Sci/R&D Officer | - | 2018 |
Members of the board | Title | Age | Since |
---|---|---|---|
Thierry Chapusot
FOU | Founder | 64 | 1996 |
Director/Board Member | 46 | 2017 | |
Director/Board Member | 58 | 1999 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 487 M€ | +8.88% | - | |
0.08% | 109 M€ | +6.82% | ||
0.08% | 191 M€ | +10.07% | ||
0.06% | 3 M€ | 0.00% | - | |
0.03% | 97 M€ | +6.85% |
Date | Price | Change | Volume |
---|---|---|---|
23-12-07 | 59.6 | -1.81% | 3,446 |
23-12-06 | 60.7 | +2.02% | 5,887 |
23-12-05 | 59.5 | -0.50% | 3,166 |
23-12-04 | 59.8 | +3.46% | 14,952 |
23-12-01 | 57.8 | -1.87% | 4,867 |
Real-time Euronext Paris, December 07, 2023 at 11:35 am EST
More quotes
Equasens is No. 1 in France for publishing and integrating software programs for pharmacies, hospitals, healthcare facilities, laboratories, retirement homes and healthcare professionals. Net sales break down by activity as follows:
- pharmacy software publishing and integration (73%): software programs for managing data bases, information, inventories, orders, electronic care records, etc.;
- publishing of IT solutions for health and medical/social establishments (15.2%): publishing and integration of software packages for retirement homes, hospitals and care homes (software for managing admissions, billing, receipt and accounting management, care management, supply management, etc.);
- development of solutions and infrastructures for e-Health (11.8%): digital communication, telemedicine and telehealth solutions. The group also offers financing solutions for leased goods (Nanceo).
Net sales are distributed geographically as follows: France (90.9%), Italy (4.9%), Belgium and Luxembourg (2.7%), Ireland and the United Kingdom (0.8%) and Germany (0.7%).
Sector
IT Services & Consulting
Calendar
2024-02-05
- Q4 2023 Sales and Revenue Release
Trading Rating :
Investor Rating :
ESG Refinitiv :
-
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
59.6EUR
Average target price
83.38EUR
Spread / Average Target
+39.90%
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.21% | 985 M $ | |
+25.58% | 211 B $ | |
+11.00% | 158 B $ | |
+13.72% | 146 B $ | |
-3.71% | 95 567 M $ | |
-2.80% | 73 220 M $ | |
+30.49% | 60 746 M $ | |
+128.10% | 57 495 M $ | |
+27.78% | 43 202 M $ | |
+22.15% | 35 321 M $ |